CAM
NEO icon

Cresset Asset Management’s NeoGenomics NEO Stock Holding History

Cresset Asset Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$175K Buy
11,975
+950
+9% +$9.17K ﹤0.01% 1602
2026
Q1 		$81.8K Hold
11,025
– – ﹤0.01% 1554
2025
Q4 		$130K Buy
11,025
+132
+1% +$1.42K ﹤0.01% 1554
2025
Q3 		$84.1K Buy
+10,893
New +$76.3K ﹤0.01% 1506
2019
Q2 		– Sell
-53
Closed -$1K – 1246
2019
Q1 		$1K Buy
+53
New +$921 ﹤0.01% 1829

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Cresset Asset Management's NEO Position: Q2 2026 in Review

Cresset Asset Management increased its NeoGenomics (NEO) stake by 8.6% in Q2 2026, buying an estimated $9.17K and bringing the position to 11,975 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #1602.

Cresset Asset Management first reported a position in NEO in Q1 2019 and has held it in 5 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Cresset Asset Management held 11,975 shares of NeoGenomics worth $175K as of Q2 2026.
  • Cresset Asset Management bought 950 NeoGenomics shares in Q2 2026, an estimated $9.17K.
  • NeoGenomics made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #1602 holding.
  • Cresset Asset Management first reported a position in NeoGenomics in Q1 2019 and has held it in 5 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.